1-20 of 22
Authors: Farhad Dastmalchi
Save search
Sort by
Journal Article

CNSC-17. UPREGULATION OF CCL4 AFTER TREATMENT WITH A NOVEL MRNA VACCINE SHIFTS THE PHENOTYPE OF CCR5-EXPRESSING MICROGLIA WITHIN TUMOR MICROENVIRONMENT

PDF
Anjali Chauhan and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii44, https://doi.org/10.1093/neuonc/noae165.0173
Published: 11 November 2024
Journal Article

CNSC-30. CD4 T CELLS MEDIATED UPREGULATION OF CCL4 CHEMOKINE DRIVES GLIOBLASTOMA TUMOR MICROENVIRONMENT REPROGRAMMING FOLLOWING TREATMENT WITH A NOVEL MRNA VACCINE

PDF
Anjali Chauhan and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v29, https://doi.org/10.1093/neuonc/noad179.0114
Published: 10 November 2023
Journal Article

DDDR-29. THE HYDROGEL-CXCL9-MRNA (HCM) VACCINE RESULTS IN SIGNIFICANT ANTI-TUMOR EFFICACY THROUGH RECRUITMENT OF NATURAL KILLER (NK) CELLS

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii105, https://doi.org/10.1093/neuonc/noac209.394
Published: 14 November 2022
Journal Article

SURG-01. DEVELOPMENT OF MURINE MODEL OF LASER INTERSTITIAL THERMOTHERAPY (LITT) FOR BRAIN TUMORS

PDF
Matthew Frain and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii251, https://doi.org/10.1093/neuonc/noac209.967
Published: 14 November 2022
Journal Article

IMMU-33. CCL4 DRIVES GLIOBLASTOMA (GBM) TUMOR MICROENVIRONMENT (TME) REPROGRAMMING AFTER TREATMENT WITH A NOVEL MRNA VACCINE

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii138, https://doi.org/10.1093/neuonc/noac209.530
Published: 14 November 2022
Journal Article

CBIO-16. DOSE INTENSIFIED TEMOZOLOMIDE IMPROVES INFILTRATION OF CD70 CAR T CELLS INTO THE GBM TUMOR MICROENVIRONMENT

PDF
Aida Karachi and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi30, https://doi.org/10.1093/neuonc/noab196.116
Published: 12 November 2021
Journal Article

IMMU-20. HYDROGEL-CXCL9 VACCINE RESULTS IN MRNA DELIVERY TO DENDRITIC CELLS AND POTENT ANTI-TUMOR RESPONSES IN GBM

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi96, https://doi.org/10.1093/neuonc/noab196.379
Published: 12 November 2021
Journal Article

BIOM-36. THE UNIQUE METABOLOMICS BASED BIOMARKERS OF RESPONSE TO IMMUNOTHERAPY FOR GLIOBLASTOMA

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii9, https://doi.org/10.1093/neuonc/noaa215.035
Published: 09 November 2020
Journal Article

IMMU-24. TEMOZOLOMIDE INDUCED IMMUNE DYSFUNCTION REQUIRES THE PRESENCE OF INTRACRANIAL TUMORS

PDF
Aida Karachi and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii109–ii110, https://doi.org/10.1093/neuonc/noaa215.454
Published: 09 November 2020
Journal Article
EDITOR'S CHOICE

Adult immuno-oncology: using past failures to inform the future

PDF
Maryam Rahman and others
Neuro-Oncology, Volume 22, Issue 9, September 2020, Pages 1249–1261, https://doi.org/10.1093/neuonc/noaa116
Published: 11 May 2020
Journal Article

EXTH-15. INCREASING THE TRAFFICKING OF DENDRITIC CELLS VIA CXC CHEMOKINE SIGNALING PATHWAY LEADS TO IMPROVED ANTI-TUMOR EFFICACY OF DENDRITIC CELL VACCINES

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi85, https://doi.org/10.1093/neuonc/noz175.349
Published: 11 November 2019
Journal Article

IMMU-07. CELLULAR IMMUNOTHERAPY TO OVERCOME TEMOZOLOMIDE INDUCED T CELL EXHAUSTION IN GLIOBLASTOMA

PDF
Aida Karachi and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi120, https://doi.org/10.1093/neuonc/noz175.501
Published: 11 November 2019
Journal Article

Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition

PDF
Aida Karachi and others
Neuro-Oncology, Volume 21, Issue 6, June 2019, Pages 730–741, https://doi.org/10.1093/neuonc/noz015
Published: 22 January 2019
Journal Article

IMMU-66. A NOVEL METABOLITE TO INCREASE EFFICACY OF CELLULAR IMMUNOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi136, https://doi.org/10.1093/neuonc/noy148.569
Published: 05 November 2018
Journal Article

IMMU-45. DOSE MODULATION OF TEMOZOLOMIDE HAVE DISTINCT EFFECTS ON HOST RESPONSE TO PD-1 BLOCKADE

PDF
Aida Karachi and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi131, https://doi.org/10.1093/neuonc/noy148.548
Published: 05 November 2018
Journal Article

Temozolomide for immunomodulation in the treatment of glioblastoma

PDF
Aida Karachi and others
Neuro-Oncology, Volume 20, Issue 12, December 2018, Pages 1566–1572, https://doi.org/10.1093/neuonc/noy072
Published: 04 May 2018
Journal Article

TMIC-26. IMMUNOMODULATION WITH TEMOZOLOMIDE TO IMPROVE EFFICACY OF IMMUNE CHECKPOINT INHIBITION FOR THE TREATMENT OF GLIOBLASTOMA

PDF
Aida Karachi and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi248–vi249, https://doi.org/10.1093/neuonc/nox168.1015
Published: 06 November 2017
Journal Article

IMMU-57. STRATEGY TO ENHANCE DC MIGRATION FOR INCREASED EFFICACY OF DENDRITIC CELL VACCINE IMMUNOTHERAPY

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi125, https://doi.org/10.1093/neuonc/nox168.515
Published: 06 November 2017
Journal Article

IMMU-31. IN VIVO CELLULAR TRACKING WITH 13C LABELING OF ADOPTIVELY TRANSFERRED T CELLS FOR THE TREATMENT OF BRAIN TUMORS

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi119, https://doi.org/10.1093/neuonc/nox168.489
Published: 06 November 2017
Journal Article

METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS

PDF
Farhad Dastmalchi and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi128, https://doi.org/10.1093/neuonc/nox168.527
Published: 06 November 2017